Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access August 9, 2011

Comparison of prostate cancer patient’s survival in Belarus and Lithuania

  • Giedre Smailyte EMAIL logo , Yury Averkin , Ilya Veyalkin , Sergey Krasny and Karolis Ulinskas
From the journal Open Medicine


[1] Baade P.D., Youlden D.R., Krnjacki L.J., International epidemiology of prostate cancer: geographical distribution and secular trends, Mol. Nutr. Food. Res., 2009, 53, 171–184. in Google Scholar

[2] Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P., Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol., 2007, 18, 581–592. in Google Scholar

[3] Coebergh J.W.W., Sant M., Berrino F., Verdecchia A., Survival of adult cancer patients in Europe diagnosed from 1978–1989: the EUROCARE II study, Eur. J. Cancer, 1998, 34, 2137–2178. in Google Scholar

[4] Berrino F., Capocaccia R., Coleman M.P., Estève J., Gatta G., Hakulinen T., et al., Survival of cancer patients in Europe. The EUROCARE-3 study, Annal. Oncol., 2003, 14(suppl 5), v9–155. in Google Scholar

[5] Coleman M.P., Gatta G., Verdecchia A., Estève J., Sant M., Storm H., et al., EUROCARE-3 summary: cancer survival at the end of 20th century, Annal. Oncol., 2003, 14(suppl 5), v128–149. in Google Scholar

[6] Ederer F., Axtell L.M., Cutler S.J., The relative survival rate: a statistical methodology, Natl. Cancer Inst. Monogr., 1961, 6, 101–121 Search in Google Scholar

[7] Dickman P., [Accessed 29 June 2009], Available at Search in Google Scholar

[8] Sant M, Capocaccia R, Coleman MP, Berrino F., Gatta G., Micheli A., et al., Cancer survival increases in Europe, but international differences remain wide, Eur. J. Cancer, 2001, 37, 1659–1667. in Google Scholar

[9] Verdecchia A., Francisci S., Brenner H., Gatta G., Micheli A., Mangone L., et al., Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data, Lancet Oncol., 2007, 8, 784–796. in Google Scholar

[10] Gondos A., Bray F., Brewster D.H., Coebergh J.W., Hakulinen T., Janssen-Heijnen M.L., et al., Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries, Eur. J. Cancer, 2008, 44, 1463–1475. in Google Scholar PubMed

[11] Jemal A., Clegg L.X., Ward E., Ries L.A., Wu X., Jamison P.M., et al., Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival, Cancer, 2004, 101, 3–27. in Google Scholar PubMed

[12] Verdecchia A., Guzzinati S., Francisci S., De Angelis R., Bray F., Allemani C., et al., Survival trends in European cancer patients diagnosed from 1988 to 1999, Eur. J. Cancer, 2009, 45, 1042–1066. in Google Scholar PubMed

[13] Brenner H., Arndt V., Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis, J. Clin. Oncol., 2005, 23, 441–447. in Google Scholar PubMed

[14] Gondos A., Bray F., Hakulinen T., Brenner H., Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis, Ann. Oncol., 2009, 20, 564–573. in Google Scholar PubMed

[15] D’Ambrosio G., Samani F., Cancian M., De Mola C., Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database, Eur. J. Cancer Prev., 2004, 13, 383–386. in Google Scholar PubMed

[16] Etzioni R., Penson D.F., Legler J.M., Overdiagnosis due to prostate specific antigen screening: lessons from U.S. prostate cancer incidence trends, J. Natl. Cancer Inst., 2002, 94, 981–990. 10.1093/jnci/94.13.981Search in Google Scholar PubMed

[17] Gavin A., McCarron P., Middleton R.J., Savage G., Catney D., O’Reilly D., et al., Evidence of prostate cancer screening in a UK region, BJU Int., 2004, 93, 730–734. in Google Scholar PubMed

[18] Kumar S., Shelley M., Harrison C., Coles B., Wilt T.J., Mason M.D., Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer, Cochrane Database Syst. Rev., [2006CD006019]. 10.1002/14651858.CD006019.pub2Search in Google Scholar PubMed PubMed Central

[19] Mike S., Harrison C., Coles B., Staffurth J., Wilt T.J., Mason M.D., Chemotherapy for hormone-refractory prostate cancer, Cochrane Database Syst. Rev., [2006CD005247]. Search in Google Scholar

[20] Baade P.D., Youlden D.R., Krnjacki L.J., International epidemiology of prostate cancer: geographical distribution and secular trends, Mol. Nutr. Food Res., 2009, 53, 171–184. in Google Scholar PubMed

Published Online: 2011-8-9
Published in Print: 2011-10-1

© 2011 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 1.3.2024 from
Scroll to top button